跳至主要内容
临床试验/NCT06251869
NCT06251869招募中不适用

Electrocoagulation vs. Cold Knife Cutting in Joint Arthroplasty: A Comparative Analysis in Knee and Hip Replacement

Iuliu Hatieganu University of Medicine and Pharmacy1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2024年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
700
试验地点
1
主要终点
Knee Injury and Osteoarthritis Outcome Score (KOOS) knee subjective score

研究概览

简要总结

Comparison of clinical outcomes of electrocoagulation and non-electrocoagulation techniques in total hip and knee arthroplasty surgery

详细描述

Objectives:

A. To evaluate the effectiveness of electrocoagulation:

  • To measure the reduction in intraoperative bleeding volume when using electrocoagulation.
  • Analyse the impact of electrocoagulation on surgical visibility and accuracy during implant placement.

B. Comparison of surgical outcomes:

  • Investigate the incidence of intra- and postoperative complications, such as incidental vascular-nerve injury, wound infections, deep vein thrombosis, and implant-related problems, in patients operated on with electrocoagulation versus techniques without electrocoagulation.
  • Examine the influence of haemostatic technique on the need for blood transfusion during or after surgery.
  • Evaluation of long-term functional outcomes and patient satisfaction, including joint stability and range of motion, in both groups.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have given informed consent to the procedure
  • Patients admitted over 18 years of age
  • Patients with pathology requiring primary joint replacement (symptomatic gonarthrosis/coxarthrosis, Avascular necrosis (AVN) of the femoral head , femoral neck fractures, etc)

排除标准

  • Contraindications for major surgery or anaesthesia
  • Patients with active infections that could interfere with outcome assessment
  • Patients unable to give informed consent for psychological or cognitive reasons
  • Severe medical conditions such as coagulopathies that may significantly influence outcomes
  • Patients unable or unwilling to adhere to the required follow-up period
  • Patients who died during the study period
  • Patients with revision prosthesis operations

结局指标

主要结局

Knee Injury and Osteoarthritis Outcome Score (KOOS) knee subjective score

时间窗: the test will be administered pre operation, 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op

to objectify the recovery, score is on a scale, higher values mean a worse outcome, scale 0-168

Western Ontario and McMaster Universities Osteoarthritis index (WOMAC) subjective score

时间窗: the test will be administered pre operation, 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op

to objectify the recovery, score is on a scale, higher values mean a worse outcome, scale 0-96 .

International Knee Documentation Committee (IKDC) objective form

时间窗: the test will be administered pre operation, 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op

to objectify the recovery, score has different classifications on a scale from A to D, the latter being the worse outcome .

Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS-JR) hip subjective score

时间窗: the test will be administered pre operation, 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op

to objectify the recovery, score is on a scale, higher values mean a worse outcome, scale 0-24 .

Harris Hip Score

时间窗: the test will be administered pre operation, 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op

to objectify the recovery, score is on a scale, higher values mean a better outcome, scale 0-100 .

Forgotten Joint Score

时间窗: the test will be administered 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op

to objectify the recovery, score is on a scale, higher values mean a worse outcome, scale 0-48 .

次要结局

  • leucocyte levels(the leucocyte levels will be registered pre-operation, then post-op day: 1, 2, 3, 4, and 5. Then at 2 weeks post-operation, 6 weeks, and 3 months)
  • thrombocyte levels(the thrombocyte levels will be registered pre-operation, then post-op day: 1, 2, 3, 4, and 5. Then at 2 weeks post-operation, 6 weeks, and 3 months)
  • joint flexion angle(the measurements will be registered pre-operative, then 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op)
  • mobilisation intervals of the patient(through hospital stay of patient approximatively 4-7 days)
  • joint hyperextension angle(the measurements will be registered pre-operative, then 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op)
  • hemaglobin levels(the hemaglobin levels will be registered pre-operation, then post-op day: 1, 2, 3, 4, and 5. Then at 2 weeks post-operation, 6 weeks, and 3 months)
  • genu flexum angle(the measurements will be registered pre-operative, then 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op)
  • joint internal rotation angle(the measurements will be registered pre-operative, then 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op)
  • joint external rotation angle(the measurements will be registered pre-operative, then 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op)
  • joint abduction angle(the measurements will be registered pre-operative, then 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op)
  • Number of participants with complications(through study completion, an average of 1 year)
  • joint adduction angle(the measurements will be registered pre-operative, then 2 weeks post-operation, 6 weeks post-op, 3 months post-op, 6 months post-op, 1 year post-op)

研究者

发起方
Iuliu Hatieganu University of Medicine and Pharmacy
申办方类型
Other
责任方
Principal Investigator
主要研究者

Benea Horea

Assoc. Professor, Orthopedics and Traumatology Surgeon, MD, PhD

Iuliu Hatieganu University of Medicine and Pharmacy

研究点 (1)

Loading locations...

相似试验

Unknown
不适用
Cold Knife Versus Monopolar Electrosurgery in Abdominal IncisionsElectrosurgery Versus Scalpel
NCT04236401Al-Azhar University90
进行中(未招募)
不适用
Comparison between scraping followed by cauterization and traditional surgery in the treatment of low-risk skin cancer up to 10 millimeters in sizeMalignant neoplasm of skin, unspecifiedC44.9
RBR-534wr3Faculdade de Medicina de Botucatu
招募中
不适用
Comparison of electrocautery incision with scalpel incision in midline abdominal surgery â?? a randomized trial.
CTRI/2013/08/003870JIPMER82
招募中
不适用
Percutaneous Electrocoagulation Versus Sclerosing Foam for Patients With Incompetent Perforating VeinsIncompetent Perforating Veins
NCT04686097Second Affiliated Hospital, School of Medicine, Zhejiang University84
进行中(未招募)
1 期
Electrochemotherapy versus conventional surgery in treatment of basal cell carcinomaBasal cell carcinoma of the skinMedDRA version: 12.1Level: LLTClassification code 10004146Term: Basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10004148Term: Basal cell carcinoma excisionMedDRA version: 12.1Level: LLTClassification code 10004149Term: Basal cell carcinoma skin excisionMedDRA version: 12.1Level: LLTClassification code 10024542Term: Lip basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10027492Term: Metatypical basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10027981Term: Morpheaform basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10029496Term: Nodulo-ulcerative basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10035029Term: Pigmented basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10039716Term: Sclerosing basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10042503Term: Superficial basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10062787Term: Morphoeaform basal cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10064679Term: Basal cell carcinoma of skin in situMedDRA version: 12.1Level: PTClassification code 10004146Term: Basal cell carcinoma
EUCTR2010-019260-37-IECork Cancer Research Centre100